News

Information on some of the most commonly prescribed medications in workers’ compensation. Claims professionals can use this guidebook as a resource that provides easy access to information regarding indications, generic availability and possible alternatives.

While electronic prescribing has become the norm in group health care, the adoption rate within workers’ compensation has been slow. Phil Walls, Chief Clinical Officer, uncovers some of the barriers to adoption in workers’ compensation, the benefits of continued implementation and the advanced innovative opportunities e-prescribing can help us achieve: patient safety, convenience and value to payers. Along with insights from Surescripts and the Surescripts Network Alliance, we are able to see the positive impact it has had in group health and the ways it can help address long-stand issues and inefficiencies in this industry.

Advanced automation and decision intelligence tools have tremendous potential to streamline workflows and improve efficiency for claims professionals, eliminating pain points and freeing up the workforce to focus on patient engagement and better outcomes. Learn more from Mike Cirillo, President of myMatrixx, along with Paul King, Chief Client Officer and Cliff Belliveau, Chief Innovation Officer, in this one-hour Risk & Insurance webinar.

A prospective policy update in Florida sparks renewed interest around the risks of physician dispensing.

myMatrixx is heading to the 2022 National Workers’ Compensation and Disability Conference (NWCDC) in Las Vegas at the Mandalay Bay Resort. Learn all the ways you can connect with us including attending our program sessions, visiting our new Innovation Studio and more!

This month, myMatrixx's own Phil Walls, Chief Clinical Officer, will be featured at the 2022 Workers' Compensation & Risk Conference and present "Barriers to Adoption; Realizing the Potential of Electronic Prescribing."

Last month, the Florida Division of Workers' Compensation (DWC) Announced plans to rescind a 2020 policy allowing treating physicians to dispense drugs while compelling reimbursement from payers. Read how myMatrixx was instrumental in engaging with key stakeholders on this topic and key points to consider as the DWC drafts proposed regulations this September.

myMatrixx is heading to the 2022 Workers' Compensation Institute (WCI) conference being hold at the Orlando World Center Marriott August 21 - 24. View all the ways you can connect with us while attending the conference!

When discussing the growing cost of drugs, we tend to frame the topic around name-brand versus generic drugs, with a view that despite the cost-saving opportunities of generics, overall spending on drugs continues to increase. However, segmenting the drug market into categories beyond purely brand versus generic drugs enables us to more accurately identify the major trends and drivers for drug prices in workers’ compensation.

This month, myMatrixx will be featured at two upcoming conferences: 2022 National Rx Drug Abuse & Heroin Summit and the AZ Self Insurers Virtual Seminar.